Sanofi, Voyager Therapeutics rejig gene therapy partnership
Voyager will gain worldwide rights to its Huntington's disease therapy candidate, transfer rights to another product candidate to Neurocrine and pay Sanofi $20 million.
Larger-than-life biotech figure Henri Termeer dies at 71
A shining light for the biotechnology industry, for Kendall Square, and for patients with rare diseases has passed away. Henri Termeer founded and led Genzyme for close to 30 years, greatly influencing the rise of biotech and bringing a patient-centric approach to the business.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Genzyme spinout X4 Pharmaceuticals lays out clinical plan
The company's CXCR4 inhibitors work to modulate the tumor microenvironment - improving the efficacy of the immune system in fighting cancer.
Cleveland Clinic & Genzyme will jointly pursue new approaches to treating multiple sclerosis
In the latest pharma-academia partnership, Genzyme and Cleveland Clinic researchers will align their efforts to better understand and treat multiple sclerosis. Their new research collaboration will span at least five years and will be led by a steering committee of researchers from both organizations, Genzyme said. Initially, their work will focus on better understanding the […]
Lysosomal storage disorder treatment moving into proof-of-concept phase
A company formed to develop protein therapeutics to treat lysosomal storage diseases — rare genetic disorders that affect the metabolism of certain natural biological substances in cells — is raising $5 million in a series A financing round, according to a filing with the U.S. Securities and Exchange Commission With the investment, the company is […]
FDA warning for Johnson & Johnson’s DePuy curtails joint replacement (Morning Read)
Current medical news and unique business news for anyone who cares about healthcare. J&J company responds to FDA warning Johnson & Johnson’s (NYSE: JNJ) subsidiary DePuy Orthopaedics received a warning letter from U.S. regulators not to sell joint replacement products without proper approval. The Dec. 8 letter said a federal investigation at DePuy’s Warsaw, Indiana […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Sanofi to restructure North American operations
French pharmaceutical company Sanofi (NYSE: SNY) said it will shut down its Bridgewater, New Jersey-based research and development facilities and consolidate them in its Boston hub. The company said it could not say how many jobs would be cut when its Bridgewater r&d facilities shut in the fourth quarter of 2012. It will set up […]
Thank you Genzyme. Biotech investing will shift to mid-sized firms (Morning Read)
Among today’s current medical news: The Genzyme-Sanofi effect, seeking clarity from Judge Vinson, pharma's friendly nurses, doctor tweets and healthcare social media, and a Medicare fraud sweep that won't make a dent.
Genzyme selling diagnostics business for $265 million
Genzyme Corp. sells off its diagnostics business to Sekisui Chemical Co. Ltd. for $265 million in cash. Genzyme Corp. (NSDQ:GENZ) is planning to sell off its diagnostics business to Tokyo-based Sekisui Chemical Co. Ltd. (TYO:4204) for $265 million in cash. The Cambridge, Mass.-based biotech giant said Sekisui will buy “substantially all of the assets” of […]
Genzyme CEO sheds stock in heart pump maker Abiomed
Genzyme Corp. (NASDAQ:GENZ) CEO Henri Termeer has cut his stake in Danvers, Massachusetts-based Abiomed Inc. (NASDAQ:ABMD) by about 5.4 percent over the past year.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
In-vitro fertilization pioneer wins Nobel Prize (Morning Read)
Robert Edwards of Britain, an 85-year-old professor emeritus at the University of Cambridge who started working on in-vitro fertilization as early as the 1950s, won the 2010 Nobel Prize in medicine on Monday for developing the breakthrough that has helped millions of infertile couples worldwide have children, according to the Associated Press in the Washington Post.
Genzyme selling genetic testing unit (Morning Read)
ambridge, Mass., biotech firm Genzyme Corp. is selling its genetic testing business to Laboratory Corp. of America Holdings for $925 million so it can focus on its core growth areas.
One reason why U.S. healthcare is so expensive (Morning Read)
Stephen Hemsley, CEO of UnitedHealth Group, topped Modern Healthcare's list of highest-paid executives at $106 million -- $7.5 million in salary and benefits and $98.5 million in stock options in 2009. Hemsley is not alone, says an editorial in St. Louis Today. The CEOs at insurance giants Cigna, Humana, Aetna, Coventry Health Systems and WellPoint all took home between $10 million and about $18 million.
What’s the most stressful job in healthcare? (Morning Read)
That'd be medical resident, according to the Christian Science Monitor, which includes the job at No. 5 on its list of the most stressful.
Do any doctors want to practice in rural America? (Morning Read)
A $1 billion effort by the Obama administration to relieve the physician shortage in rural America by subsidizing med school debt for young physicians is running up against a problem--not in attracting docs in the first place, but keeping them there once their initial three-to-five-year commitment is up.